InsidersTradesSigma
Alligator Bioscience AB: insider trades · Finland · FIN-FSA
FI:alligator-bioscience-ab-2449fdSE0024173637FI·FIN-FSAMcap 141M€Healthcare
Discover the full management transaction log of Alligator Bioscience AB, a publicly traded company based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Alligator Bioscience AB has recorded 3 insider filings. Market capitalisation: €140.7m. The latest transaction was reported on 16 September 2025 (Purchase). Among the most active insiders: Peter Ostler. Every trade is openly available.
3
Insider Decl.
0
Thresholds
€22,549
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
0.22 €
Analyst consensus
1 analystsStrong buy
0.30 €Target 0.30 €(+34%)0.30 €
Income statement
Revenue514 k€
Net income−51.4 M€-9990.3% margin
Valuation
P/Book1.4x
Beta1.24
Balance sheet & cash
Market cap140.7 M€
Total debt43.2 M€
Free Cash Flow−157.4 M€
Debt / Equity78%
Profitability & ownership
ROA-62.9%
% insiders16.5%
% institutions1.9%
Last declaration on 16 September 2025
Declarations3 total
Executives●Purchase13FIN-FSA
€6,70223,456 shares@ €0.28570.0048% mcap29.7% of flow
Aktie
FI:A003S331-1·
Ideal exit: 12 Jun 2026 (T+270)
Executives●Other30FIN-FSA
€2,85710,000 shares@ €0.28570.0020% mcap100.0% of flow
Aktie
FI:A003S326-1·
Executives●Purchase18FIN-FSA
€15,84746,912 shares@ €0.33780.011% mcap70.3% of flow
Aktie
FI:A003O690-1·
Ideal exit: 13 Feb 2026 (T+270)
3 of 3 declarations